Hull Public Health 

The Deep, Hull The Guildhall, Hull King William Statue, Market Place, Hull City Hall, Hull Spurn Lightship, The Marina, Hull

 

 

Screening


Documents

The main documents containing information on screening are as follows:

JSNA
Hull JSNA Toolkit: Screening
Public Health Outcomes Framework Main Report (to open this report on a particular PHOF indicator, click here)
Public Health Outcomes Framework Summary
Attitudes to Health Survey 2007

Back to top


Background

The main national screening programmes in England are those in antenatal care and for the newborn which include screening for Down's Syndrome, fetal anomaly ulstrasound scan, infectious diseases in pregnancy, antenatal sickle cell and thalassaemia, newborn and infant physical examination, newborn blood spot for phenylketonuria and newborn hearing screening. There are also national screening programmes for young people and adults for abdominal aortic aneurysm, diabetic retinopathy, breast, cervical and colorectal cancer. There are also other related programmes such as the Prostate Cancer Risk Management, National Chlamydia Screening Programme which provides screening for young people under 25 and the NHS Health Check programme aims to help prevent circulatory diseases (including heart disease and stroke), diabetes and kidney disease, with checks undertaken once every five years for those aged 40-74 years who are not already diagnosed with one of these conditions.

Screening uptake rates are presented in Hull JSNA Toolkit: Screening for breast, cervical and colorectal cancer screening by general practice, deprivation and/or ward. Screening uptake rates for breast cancer, colorectal cancer, diabetic reinopathy and the NHS Health Check as well as some of the screening undertaken in antenatal care are also within the Public Health Outcomes Framework and further analysis is given within the Public Health Outcomes Framework Main Report (to open this report on a particular PHOF indicator, click here) and Public Health Outcomes Framework Summary.

Factors influencing breast and cervical cancer screening have also been examined in Hull JSNA Toolkit: Screening. Attitudes towards screening and health checks were also collected in the Attitudes to Health Survey 2007.

There are also vaccination and immunisation programmes in place, see Vaccination and Immunisation for more information.

Back to top


Abdominal Aortic Aneurysm

Information is presented within Hull JSNA Toolkit: Screening for the NHS Abdominal Aortic Aneurysm (AAA) Screening Programme, the Public Health Outcomes Framework Main Report (to open this report on a particular PHOF indicator, click here) and the Public Health Outcomes Framework Summary Report. There is some discussion on non-cancer screening in relation to the Public Health Outcomes Framework within Hull JSNA Toolkit: Screening.

Back to top


Antenatal Screening

There are some indicators within Public Health Outcomes Framework relating to screening undertaken in antenatal care although data are not currently available for further analysis. The indicators include the percentage of pregnant women eligible for screening who are tested leading to a conclusive result for:

i) HIV
ii) Syphilis, hepatitis B and susceptibility to rubella
iii) Antenatal sickle cell and thalassaemia

There are also some indicators related to screening of the newborn baby which can be found in the Public Health Outcomes Framework Main Report (to open this report on a particular PHOF indicator, click here) and the Public Health Outcomes Framework Summary Report.

Back to top


Attitudes to Health and Screening

The Attitudes to Health Survey 2007 examined attitudes to health as well as risk factors for health such as smoking, diet, exercise, obesity, etc. Attitudes to screening and health checks were also investigated. A summary of the findings is also given in the JSNA Toolkit.

Back to top


Bloodspot Newborn Screening

Uptake of screening for phenylketonuria using 'bloodspot screening' is an indicator within Public Health Outcomes Framework and further analysis is given within the Public Health Outcomes Framework Main Report (to open this report on a particular PHOF indicator, click here) and Public Health Outcomes Framework Summary.

Back to top


Breast Cancer

Information relating to risk factors, incidence, hospital admissions, mortality, survival and screening is included within Hull JSNA Toolkit: Breast Cancer.

Uptake rates for breast cancer screening and factors influencing uptake are also given within the JSNA Toolkit.

Breast cancer screening uptake is an indicator within Public Health Outcomes Framework and further analysis is given within the Public Health Outcomes Framework Main Report (to open this report on a particular PHOF indicator, click here) and Public Health Outcomes Framework Summary.

Information is also available in the Cancer Equity Audit.

General information relating to Cancer is also available.

Back to top


Cancer

Information relating to screening as well as risk factors, incidence, hospital admissions, mortality and survival is included within Hull JSNA Toolkit: All Cancers. General information relating to Cancer is also available.

Uptake rates for breast, cervical and bowel cancer screening and factors influencing uptake in breast and cervical cancer is also given within Hull JSNA Toolkit: Screening.

Breast cancer and cervical cancer screening uptake is an indicator within Public Health Outcomes Framework and further analysis is given within the Public Health Outcomes Framework Main Report (to open this report on a particular PHOF indicator, click here) and Public Health Outcomes Framework Summary.

Information is also included within the Cancer Equity Audit which was finalised July 2006.

Back to top


Cervical Cancer

The number of deaths are relatively small per year, but information is included on the incidence in the general section relating to the incidence of cancer and the number of deaths is given within the cause of death section within Hull JSNA Toolkit: All Cancers.

Uptake rates for cervical cancer screening and factors influencing uptake are given within Hull JSNA Toolkit: Screening.

Cervical cancer screening uptake is an indicator within Public Health Outcomes Framework and further analysis is given within the Public Health Outcomes Framework Main Report (to open this report on a particular PHOF indicator, click here) and Public Health Outcomes Framework Summary.

Information is also available in the Cancer Equity Audit.

General information relating to Cancer is also available.

Back to top


Chlamydia

The diagnosis rate of Chlamydia is given in the Hull JSNA Toolkit: Sexual Health together with the numbers aged 15-24 years who were tested for Chlamydia.

The crude rate of Chlamydia diagnoses per 100,000 young adults aged 15-24 years is an indicator within Public Health Outcomes Framework and further analysis is given within the Public Health Outcomes Framework Main Report (to open this report on a particular PHOF indicator, click here) and Public Health Outcomes Framework Summary. This indicator gives an indication of the numbers screened for Chlamydia.

Back to top


Colorectal Cancer

Information relating to risk factors, incidence, hospital admissions, mortality, survival and screening is included within Hull JSNA Toolkit: Colorectal Cancer.

Information is also available in the Cancer Equity Audit.

General information relating to Cancer is also available.

Back to top


Diabetic Retinopathy Screening

Uptake rates for diabetic retinopathy screening is an indicator within Public Health Outcomes Framework and further analysis is given within the Public Health Outcomes Framework Main Report (to open this report on a particular PHOF indicator, click here) and Public Health Outcomes Framework Summary.

Information is also included within the Diabetes Equity Audit which was finalised in October 2008.

General information relating to Diabetes is also available.

Back to top


Factors Influencing Screening Uptake

Factors influencing screening uptake for breast cancer and cervical cancer are examined within Hull JSNA Toolkit: Screening.

Back to top


General Practices

The general practices in Hull differ with regard to their registered population in terms of deprivation and age of patients. Whilst general practices can be compared, it is better and easier to try to compare like-with-like. As a result, the general practices in Hull have been grouped according to the average deprivation score of their patients and the average age of their patients. The General Practice Comparator Groupings document provides further details.

Information at practice level in relation to cancer screening is presented within Hull JSNA Toolkit: Screening. Information is also available in the Cancer Equity Audit.

Back to top


Health Equity Audits

Information relating to cancer screening and diabetic retinopathy screening are given in the following equity audits:

Diabetes Equity Audit – October 2008
Cancer Equity Audit – July 2006

Back to top


Hearing Test Screening Among Newborn Babies

Uptake of the hearing test for newborn babies is an indicator within Public Health Outcomes Framework although data are currently unavailable for further.

Back to top


Hepatitis B

Screening uptake for syphilis, hepatitis B and susceptibility to rubella for eligible pregnant women is an indicator within Public Health Outcomes Framework and further analysis is given within the Public Health Outcomes Framework Main Report (to open this report on a particular PHOF indicator, click here) and Public Health Outcomes Framework Summary.

Back to top


HIV

Uptake rate for HIV testing among eligible pregnant women is an indicator within Public Health Outcomes Framework and further analysis is given within the Public Health Outcomes Framework Main Report (to open this report on a particular PHOF indicator, click here) and Public Health Outcomes Framework Summary.

Further information on HIV is also given within Hull JSNA Toolkit: Sexual Health.

Back to top


Immunisation

– see Vaccination and Immunisation

Back to top


Newborn Screening and Examination

There are some indicators within Public Health Outcomes Framework relating to tests and examinations of newborn babies including the 'bloodspot screening' (an indicator for phenylketonuria), hearing test and physical examination and further analysis is given within the Public Health Outcomes Framework Main Report (to open this report on a particular PHOF indicator, click here) and Public Health Outcomes Framework Summary.

Back to top


NHS Health Check

NHS Health Check programme aims to help prevent cardiovascular disease (including heart disease and stroke), diabetes and kidney disease, with checks undertaken once every five years for those aged 40-74 years who are not already diagnosed with one of these conditions.

There are two indicators relating to the NHS Health Check Programme within Public Health Outcomes Framework and further analysis is given within the Public Health Outcomes Framework Main Report (to open this report on a particular PHOF indicator, click here) and Public Health Outcomes Framework Summary. The indicators are:

i) Percentage of Health Checks offered out of the eligible population
ii) Percentage of Health Checks completed out of those offered health checks

Back to top


Non-cancer Screening

Information is presented within Hull JSNA Toolkit: Screening at for the NHS Abdominal Aortic Aneurysm (AAA) Screening Programme. There is some discussion on non-cancer screening in relation to the Public Health Outcomes Framework within Hull JSNA Toolkit: Screening.

A number of indicators within the Public Health Outcomes Framework relate to screening in antenatal care and screening of the newborn baby although data is currently unavailable for further analysis. The indicators include the percentage of pregnant women eligible for screening who are tested leading to a conclusive result for:

i) HIV
ii) Syphilis, hepatitis B and susceptibility to rubella
iii) Antenatal sickle cell and thalassaemia

There are also some indicators related to screening of the newborn baby including the 'bloodspot screening' (an indicator for phenylketonuria), hearing test and physical examination and further analysis is given within the Public Health Outcomes Framework Main Report (to open this report on a particular PHOF indicator, click here) and Public Health Outcomes Framework Summary.

Uptake rates for diabetic retinopathy screening and the NHS Health Check Programme are indicators within Public Health Outcomes Framework and further analysis is given within the Public Health Outcomes Framework Main Report (to open this report on a particular PHOF indicator, click here) and Public Health Outcomes Framework Summary.

Information relating to diabetic retinopathy screening is also given in the Diabetes Equity Audit completed October 2008.

Back to top


Phenylkentonuria Bloodspot Newborn Screening

Uptake of screening for phenylketonuria using 'bloodspot screening' is an indicator within Public Health Outcomes Framework although data are currently unavailable for further analysis.

Back to top


Physical Examination for Newborns

There are some indicators within the Public Health Outcomes Framework relating to tests and examinations of newborn babies including the 'bloodspot screening' (an indicator for phenylketonuria), hearing test and physical examination although data are currently unavailable for further analysis.

Back to top


Pregnancy

There are some indicators within Public Health Outcomes Framework relating to screening of pregnant women against disease although data are currently unavailable for further analysis. The indicators include the percentage of pregnant women eligible for screening who are tested leading to a conclusive result for:

i) HIV
ii) Syphilis, hepatitis B and susceptibility to rubella
iii) Antenatal sickle cell and thalassaemia

There are also some indicators related to screening of the newborn baby.

Back to top


Public Health Outcomes Framework

A number of indicators within Public Health Outcomes Framework relate to screening in antenatal care and screening of the newborn baby although data are currently unavailable for further analysis. The indicators include the percentage of pregnant women eligible for screening who are tested leading to a conclusive result for:

i) HIV
ii) Syphilis, hepatitis B and susceptibility to rubella
iii) Antenatal sickle cell and thalassaemia

There are also some indicators related to screening of the newborn baby including the 'bloodspot screening' (an indicator for phenylketonuria), hearing test and physical examination.

For adults, uptake rates for breast and cervical cancer and diabetic retinopathy screening, and the take up of the NHS Health Check Programme are indicators within Public Health Outcomes Framework and further analysis is given within the Public Health Outcomes Framework Main Report (to open this report on a particular PHOF indicator, click here) and Public Health Outcomes Framework Summary.

Back to top


Rubella

Screening uptake for syphilis, hepatitis B and susceptibility to rubella for eligible pregnant women is an indicator within the Public Health Outcomes Framework and further analysis is given within the Public Health Outcomes Framework Main Report (to open this report on a particular PHOF indicator, click here) and Public Health Outcomes Framework Summary.

Back to top


Screening

Information on screening for breast, cervical and colorectal cancers are given within Hull JSNA Toolkit: Screening at practice level. Breast and cervical cancer screening uptake is examined in relation to age and deprivation, and the relationship between breast and cervical cancer screening uptake rates are compared for each practice. Information is also presented for the NHS Abdominal Aortic Aneurysm (AAA) Screening Programme.

Information relating to cancer screening and diabetic retinopathy screening are given in the following equity audits:

Diabetes Equity Audit – October 2008
Cancer Equity Audit – July 2006

For adults, uptake rates for breast and cervical cancer screening and diabetic retinopathy screening, and the take up of the NHS Health Check Programme are indicators within Public Health Outcomes Framework and further analysis is given within the Public Health Outcomes Framework Main Report (to open this report on a particular PHOF indicator, click here) and Public Health Outcomes Framework Summary.

There is some discussion on non-cancer screening in relation to the Public Health Outcomes Framework within the JSNA Toolkit.

A number of indicators within Public Health Outcomes Framework relate to screening in antenatal care and screening of the newborn baby although data are currently unavailable for further analysis. The indicators include the percentage of pregnant women eligible for screening who are tested leading to a conclusive result for:

i) HIV
ii) Syphilis, hepatitis B and susceptibility to rubella
iii) Antenatal sickle cell and thalassaemia

There are also some indicators related to screening of the newborn baby including the 'bloodspot screening' (an indicator for phenylketonuria), hearing test and physical examination and further analysis is given within the Public Health Outcomes Framework Main Report (to open this report on a particular PHOF indicator, click here) and Public Health Outcomes Framework Summary.

The number of cases of Chlamydia diagnosed is also an indicator within the Public Health Outcomes Framework which is related to screening and further analysis is given within the Public Health Outcomes Framework Main Report (to open this report on a particular PHOF indicator, click here) and Public Health Outcomes Framework Summary. The number of cases of Chlamydia diagnosed is given within the JSNA Toolkit.

Associated information, including information on human papillomavirus (HPV) types 16 and 18 vaccine (for some types of cervical cancer) is given in Vaccinations and Immunisations.

Back to top


Sickle Cell

Sickle cell screening among pregnant women is an indicator within Public Health Outcomes Framework although data are currently unavailable for further analysis.

Back to top


Syphilis

Screening uptake for syphilis, hepatitis B and susceptibility to rubella for eligible pregnant women is an indicator within the Public Health Outcomes Framework although data are currently unavailable for further analysis.

Back to top


Thalassaemia

Thalassaemia screening among pregnant women is an indicator within the Public Health Outcomes Frameworkalthough data are currently unavailable for further analysis.

Back to top


Tuberculosis

Information is given on tuberculosis within Hull JSNA Toolkit: Infectious Diseases.

The incidence rate and percentage completing treatment for tuberculosis are indicators within the Public Health Outcomes Framework and further analysis is given within the Public Health Outcomes Framework Main Report (to open this report on a particular PHOF indicator, click here) and Public Health Outcomes Framework Summary.

The incidence rate and percentages completing treatment will depend on the how many people and which groups of people are screened for tuberculosis. Recent increases in immigrants from particular countries with higher prevalence rates of tuberculosis will have increased the need for tuberculosis screening and treatment locally.

Back to top


Vaccinations

– see Vaccination and Immunisation

Back to top